
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Cancer and Radiation Epidemiology Unit and 2 Biostatistics Unit, Gertner Institute and 3 Susanne Levy-Gertner Oncogenetics Unit, Sheba Medical Center; 4 Danek Gertner Institute of Genetics, Tel Hashomer, Israel; 5 Occupational and Environmental National Health Institute, Ra'anana, Israel; and 6 Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Requests for reprints: Siegal Sadetzki, Cancer Epidemiology Unit, Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel 52621. Phone: 972-3-5303262; Fax: 972-3-5348360. E-mail: siegals{at}gertner.health.gov.il
Ionizing radiation is the most established risk factor for meningioma formation. Our aim was to evaluate the main effect of selected candidate genes on the development of meningioma and their possible interaction with ionizing radiation in the causation of this tumor. The total study population included 440 cases and controls: 150 meningioma patients who were irradiated for tinea capitis in childhood, 129 individuals who were similarly irradiated but did not develop meningioma, 69 meningioma patients with no previous history of irradiation, and 92 asymptomatic population controls. DNA from peripheral blood samples was genotyped for single nucleotide polymorphisms (SNP) in 12 genes: NF2, XRCC1, XRCC3, XRCC5, ERCC2, Ki-ras, p16, cyclin D1, PTEN, E-cadherin, TGFB1, and TGFBR2. SNP analysis was done using the MassArray system (Sequenom, San Diego, CA) and computerized analysis by SpectroTYPER. Logistic regressions were applied to evaluate main effect of each gene on meningioma formation and interaction between gene and radiation. Intragenic SNPs in the Ki-ras and ERCC2 genes were associated with meningioma risk (odds ratio, 1.76; 95% confidence interval, 1.07-2.92 and odds ratio, 1.68; 95% confidence interval, 1.00-2.84, respectively). A significant interaction was found between radiation and cyclin D1 and p16 SNPs (P for interaction = 0.005 and 0.057, respectively). Our findings suggest that Ki-ras and ERCC2 SNPs are possible markers for meningioma formation, whereas cyclin D1 and p16 SNPs may be markers of genes that have an inverse effect on the risk to develop meningioma in irradiated and nonirradiated populations.
This article has been cited by other articles:
![]() |
Y. Liu, M. E. Scheurer, R. El-Zein, Y. Cao, K.-A. Do, M. Gilbert, K. D. Aldape, Q. Wei, C. Etzel, and M. L. Bondy Association and Interactions between DNA Repair Gene Polymorphisms and Adult Glioma Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 204 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Davis, B. S. Malmer, K. Aldape, J. S. Barnholtz-Sloan, M. L. Bondy, T. Brannstrom, J. M. Bruner, P. C. Burger, V. P. Collins, P. D. Inskip, et al. Issues of Diagnostic Review in Brain Tumor Studies: From the Brain Tumor Epidemiology Consortium Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 484 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, H. Zhang, K. Zhou, L. Chen, Z. Xu, Y. Zhong, H. Liu, R. Li, Y. Y. Shugart, Q. Wei, et al. Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma Carcinogenesis, September 1, 2007; 28(9): 1906 - 1913. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rajaraman, S. S. Wang, N. Rothman, M. M. Brown, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, S. J. Chanock, et al. Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wrensch, K. T. Kelsey, M. Liu, R. Miike, M. Moghadassi, J. D. Sison, K. Aldape, A. McMillan, J. Wiemels, and J. K. Wiencke ERCC1 and ERCC2 polymorphisms and adult glioma Neuro-oncol, October 1, 2005; 7(4): 495 - 507. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |